Location History:
- Vincent, AU (1999 - 2003)
- Box Hill, AU (1999 - 2010)
Company Filing History:
5 out of 122 
3 out of 7 
1 out of 1 Years Active: 1999-2010
Title: **Christopher Vincent Doidge: Innovator in Biopharmaceuticals**
Introduction
Christopher Vincent Doidge is a renowned inventor based in Box Hill, Australia, with a significant contribution to the field of biopharmaceuticals. With a total of nine patents to his name, Doidge has exemplified innovation in developing novel treatments to combat infectious diseases, especially those caused by Helicobacter pylori.
Latest Patents
Among his latest patents is a remarkable innovation titled "Polypeptide fragments comprising C-terminal portion of Helicobacter catalase." This patent describes isolated polypeptides and their immunogenic fragments, which serve as novel agents for treating or preventing infections in mammalian hosts. Notably, the polypeptide consists of a C-terminal portion of catalase that lacks significant amino acid sequence identity with human catalase, indicating its potential uniqueness in therapeutic applications. Additionally, he holds a patent for "Protective Helicobacter antigens," which focuses on the use of Helicobacter pylori antigens in the treatment and prevention of gastroduodenal diseases associated with H. pylori infection.
Career Highlights
Throughout his career, Doidge has worked with several esteemed companies, including CSL Limited, where he has played a pivotal role in advancing biopharmaceutical innovations. His experience in these environments has allowed him to refine his skills and contribute effectively to the field of immunology, making strides in the development of preventative and therapeutic solutions.
Collaborations
Doidge's journey has been marked by fruitful collaborations with notable colleagues, including Adrian Lee and Stuart L. Hazell. These professional relationships have facilitated the exchange of ideas and expertise, leading to significant advancements in their shared objectives in biopharmaceutical research.
Conclusion
Christopher Vincent Doidge stands out as a prominent figure in the realm of biopharmaceutical innovation. His nine patents underscore a commitment to enhancing healthcare through novel immunogenic agents and protective antigens. As he continues to work on groundbreaking projects, Doidge's contributions are sure to have lasting impacts on the treatment and prevention of infectious diseases.